Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma

Figure 4

Evaluation of tumor immune microenvironment. (a) Landscape of 22 kinds of tumor-infiltrating immune cells evaluated by CIBERSORTx; (b) infiltration abundance of 22 immune cells differed between immune-activated and immunosuppressive groups; (c) landscape of 6 kinds of tumor-infiltrating immune cells evaluated by EPIC; (d) differences on infiltration abundance of 6 immune cells between immune-activated and immunosuppressive groups; (e) Venn analysis for screening the DEIRGs between immune gene sets and DEGs; (f) the enriched T cells (f) and macrophages (g) related biological processes for DEIRGs.

(a)

(b)

(c)

(d)

(e)

(f)

(g)